Figure 4From: A systematic review of gemcitabine and taxanes combination therapy randomized trials for metastatic breast cancerEffect of GT-based combination therapy versus non GT-based combination for MBC. HR were analyzed with the fixed effect model. (A: Meta-analysis of OS, subgroup: therapy lines; B: Meta-analysis of OS, subgroup: gemcitabine role).Back to article page